Peanut allergy drug approved by the US FDA

After a long quest, the US has finally found a treatment for peanut allergies for children. Based on sources, Palforzia, drug AR101, uses oral immunotherapy and is given in tiny, increasing amounts to children. Palforzia, has been approved for use in patients between four and 17. It is a powder, to be sprinkled on food.

The doses contain peanut protein and under medical supervision is given over a period of six months. After this users can continue to take a daily dose in order to tolerate accidental exposure. According to experts, the treatment is not a cure, hence warn about the risk of potentially fatal anaphylactic reactions which remains. As a regard of which, patients must still continue to avoid peanuts in their diet.

Reports suggest, peanuts are recognized as the most common food allergen in the US and marks the rise in the number of those affected by food allergies across the West in the recent decades.

The latest development marks as a significant one owning to the approval by the US Food and Drug Administration (FDA). It has however been reported that the drug has not yet been authorised for use in the UK.